Skip to content
Screener

Nuvation Bio NUVB Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$28.58B-14.0%
Pfizer logo
PfizerPFE
$42.82B-6.6%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$234.03M+59.7%
Immunome logo
ImmunomeIMNM
$594.31M+83.9%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$171.34M-23.3%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$348.7M+87.7%

Other financials

Income statement

See full
Revenue$31.7M+556%
Gross profit$9.8M+1,340%
Operating income-$51.0M+19.7%
Net income-$62.8M-6.5%
EPS (diluted)-$0.18-5.9%

Balance sheet

See full
Cash & equivalents$258.6M+4.3%
Total debt$9.5M-83.5%
Total equity$253.9M-31.9%
Total assets$744.5M+15.0%

Cash flow

See full
Operating cash flow-$43.0M+10.8%
CapEx$254.0K+40.3%
Free cash flow-$43.2M+10.6%

Valuation

See full
Market cap$2.15B+168%
Enterprise value$1.9B+211%
P/S12.6×-43.1×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-81%-39.4pp
Net margin-88.2%-42.7pp
FCF margin-75.7%-36.6pp

Returns & leverage

See full
Return on equity-47.8%-9.8pp
Debt / equity-0.1×
Current ratio8.4×-1.0×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:55 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-336646
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets13,86111,536
Marketable securities402,352365,125
Interest receivable on marketable securities3,8883,285
Total current assets726,432571,519
Property and equipment, net of accumulated depreciation of $1,331 and $1,184, respectively715564
Intangible assets, net of accumulated amortization of $2,777 and $1,856, respectively10,29211,214
Operating lease right-of-use assets3,2403,918
Other non-current assets3,8247,607

Item 1. Financial Statements.

FAQ

What is Nuvation Bio's total current assets?
Nuvation Bio (NUVB) reported total current assets of $726.43M in Q2 2026.
How has Nuvation Bio's total current assets changed year-over-year?
Nuvation Bio's total current assets increased by 16.6% year-over-year, from $623.21M to $726.43M.
What is the long-term trend for Nuvation Bio's total current assets?
Over 5 years (2020 to 2025), Nuvation Bio's total current assets has grown at a 21.0% compound annual growth rate (CAGR), from $220.68M to $571.52M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Nuvation Bio's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude